[HTML][HTML] 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American …

DO Kleindorfer, A Towfighi, S Chaturvedi, KM Cockroft… - Stroke, 2021 - journals.lww.com
1. Specific recommendations for prevention strategies often depend on the ischemic
stroke/transient ischemic attack subtype. Therefore, new in this guideline is a section …

Review and update of the concept of embolic stroke of undetermined source

HC Diener, JD Easton, RG Hart, S Kasner… - Nature Reviews …, 2022 - nature.com
Ischaemic strokes have traditionally been classified according to the TOAST criteria, in
which strokes with unclear aetiology are classified as cryptogenic strokes. However, the …

[HTML][HTML] SCAI guidelines for the management of patent foramen ovale

CJ Kavinsky, M Szerlip, AM Goldsweig, Z Amin… - Journal of the Society for …, 2022 - Elsevier
Background Patent foramen ovale (PFO) is a vestigial congenital cardiovascular structure
present in around 25% of adults. In most cases, PFO is entirely benign and requires no …

[HTML][HTML] Practice advisory update summary: patent foramen ovale and secondary stroke prevention: report of the Guideline Subcommittee of the American Academy of …

SR Messé, GS Gronseth, DM Kent, JR Kizer… - Neurology, 2020 - ncbi.nlm.nih.gov
Objective To update the 2016 American Academy of Neurology (AAN) practice advisory for
patients with stroke and patent foramen ovale (PFO). Methods The guideline panel followed …

Proposal for updated nomenclature and classification of potential causative mechanism in patent foramen ovale–associated stroke

AY Elgendy, JL Saver, Z Amin, KD Boudoulas… - JAMA …, 2020 - jamanetwork.com
Importance Recent epidemiologic and therapeutic advances have transformed
understanding of the role of and therapeutic approach to patent foramen ovale (PFO) in …

[HTML][HTML] Epidemiology of patent foramen ovale in general population and in stroke patients: a narrative review

I Koutroulou, G Tsivgoulis, D Tsalikakis… - Frontiers in …, 2020 - frontiersin.org
Introduction: Percutaneous closure of patent foramen ovale (PFO) in selected patients with
cryptogenic cerebrovascular ischemic events (CEs) decreases the risk of recurrent stroke; …

Antithrombotic therapy in patients undergoing transcatheter interventions for structural heart disease

P Calabro, F Gragnano, G Niccoli, R Marcucci… - Circulation, 2021 - Am Heart Assoc
Contemporary evidence supports device-based transcatheter interventions for the
management of patients with structural heart disease. These procedures, which include …

Tailoring the approach to embolic stroke of undetermined source: a review

H Kamel, AE Merkler, C Iadecola, A Gupta… - JAMA …, 2019 - jamanetwork.com
Importance One-third of ischemic strokes have no identifiable cause after standard
evaluation. In 2014, researchers termed theseembolic strokes of undetermined source …

Potential embolic sources and outcomes in embolic stroke of undetermined source in the NAVIGATE-ESUS trial

G Ntaios, LA Pearce, R Veltkamp, M Sharma… - Stroke, 2020 - Am Heart Assoc
Background and Purpose—Emboli in embolic stroke of undetermined source (ESUS) may
originate from various potential embolic sources (PES), some of which may respond better to …

Characteristics of recurrent ischemic stroke after embolic stroke of undetermined source: secondary analysis of a randomized clinical trial

R Veltkamp, LA Pearce, E Korompoki… - JAMA …, 2020 - jamanetwork.com
Importance The concept of embolic stroke of undetermined source (ESUS) unifies a
subgroup of cryptogenic strokes based on neuroimaging, a defined minimum set of …